Code of Maine Rules
02 - DEPARTMENT OF PROFESSIONAL AND FINANCIAL REGULATION
392 - MAINE BOARD OF PHARMACY
Part 5 - LICENSE DENIAL AND PROFESSIONAL DISCIPLINE
Chapter 36 - LICENSURE OF OPIOID TREATMENT PROGRAMS
Section 392-5-36-2 - License Required; Coordination With State and Federal Regulatory Requirements

Current through 2024-38, September 18, 2024

An opioid treatment program must obtain a license from the board. This chapter applies to opioid treatment programs that are-

Certified or provisionally certified by the U.S. Department of Health and Human Services, Substance Abuse and Mental Health Services Administration pursuant to 42 CFR Part 8; and Licensed by the Maine Department of Health and Human Services, Division of Licensing and Regulatory Services pursuant to 14-118 CMR Chapter 5, Section 19.8.

An opioid treatment program licensed by the board pursuant to this chapter must furnish copies of its federal DHHS certification, DEA number and state DHHS license to the board prior to opening for operation.

Maintenance of federal DHHS certification and state DHHS licensure as set forth above is an ongoing requirement of licensure by the board. Any loss or lapse of federal DHHS certification or state DHHS licensure may result in disciplinary action by the board.

Disclaimer: These regulations may not be the most recent version. Maine may have more current or accurate information. We make no warranties or guarantees about the accuracy, completeness, or adequacy of the information contained on this site or the information linked to on the state site. Please check official sources.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.